Cargando…
Pharmacokinetics of Budesonide Oral Suspension in Children and Adolescents With Eosinophilic Esophagitis
The pharmacokinetic (PK) profile of budesonide oral suspension (BOS) was evaluated during a phase 2, randomized, double-blind, placebo-controlled, dose-ranging study in pediatric patients with eosinophilic esophagitis (EoE) (MPI 101-01/NCT00762073). Non-compartmental methods were used to calculate P...
Autores principales: | Gupta, Sandeep K., Hill, Malcolm, Vitanza, Joanne M., Farber, Robert H., Desai, Nirav K., Williams, James, Song, Ivy H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278710/ https://www.ncbi.nlm.nih.gov/pubmed/35666852 http://dx.doi.org/10.1097/MPG.0000000000003482 |
Ejemplares similares
-
Pooled Phase 2 and 3 Efficacy and Safety Data on Budesonide Oral Suspension in Adolescents with Eosinophilic Esophagitis
por: Mukkada, Vincent A., et al.
Publicado: (2023) -
Proton-pump Inhibitor Response Prediction Using Esophageal microRNAs in Children With Eosinophilic Esophagitis
por: Cañas, José Antonio, et al.
Publicado: (2020) -
CYP2C19 and STAT6 Variants Influence the Outcome of Proton Pump Inhibitor Therapy in Pediatric Eosinophilic Esophagitis
por: Mougey, Edward B., et al.
Publicado: (2019) -
A meta-analysis on randomized controlled trials of treating eosinophilic esophagitis with budesonide
por: Liu, Xiaopei, et al.
Publicado: (2022) -
Psychometric validation of the Dysphagia Symptom Questionnaire in patients with eosinophilic esophagitis treated with budesonide oral suspension
por: Hudgens, Stacie, et al.
Publicado: (2017)